WiSys Technologies

Porous Silicon Nanomembranes for the Rapid Separation of Macromolecules by Size and Shape

WiSys is seeking a strategic partner skilled in the development and manufacturing of membranes used for the separation and/or detection of biologic molecules in solution.  There is additional interest in a partner with the expertise to identify and test novel applications for these nanomembranes.

Monomeric Fluorescent Protein-Ligand Complexes with Strong Fluorescence in the Far-Red Region

WiSys Technology Foundation is seeking a strategic partner with an industry player in the life science tools and reagents industry for the further development and commercialization of its novel monomeric fluorescent protein.

Skin Whitening Agent(s)

WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.

Fluorescent Ligand Complexes for Labeling

Anti-Anxiety Pharmaceuticals with Reduced Side Effects

Benzodiazepine Derivatives with Reduced Side Effects

The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.

Staphylococcus aureus Infection Treatment

Methods to Isolate Microbials from Fruit or Seed Extracts

Antimicrobials Isolated From Cranberry

Warfarin Promoter for Enhanced Rodenticide Efficiency

WiSys is currently seeking a strategic partner to assist in such further development providing a route to market for the commercialization of lead analogues.